TARDBP and amyotrophic lateral sclerosis: We have tested the effectiveness of the brain permeable small molecule named as IGS-2.7, a potent inhibitor of CK-1δ with some residual inhibitory activity on CK-1ε, in an in vivo preclinical study using a TDP-43 transgenic mice model of ALS.